home_slide_2.jpg
News

Great article about Abivax : what makes it a unique candidate to treat Covid-19

In addition to its exciting results in ulcerative colitis

In addition to its exciting results in ulcerative colitis, Abivax's ABX 464 has shown antiviral, anti-inflammatory and tissue repair properties in COVID-19 clinical trials.